Funding for this research was provided by:
DFG (PO732, KFO311)
Austrian Science Fund (SFB LIPOTOX F3007 & F3012, W1226, P29203, P29262, P27893, P 31727)
Deutsche Forschungsgemeinschaft (BA5631/2)
Received: 14 May 2020
Accepted: 2 December 2020
First Online: 31 January 2021
Compliance with ethical standards
: FM and SJS have equity interest in TLL The Longevity Labs. TT is founder and shareholder of Cardior Pharmaceuticals GmbH. All other authors declare that they have no conflict of interest.
: Husbandry and procedures involving animals were carried out according to the German Animal Welfare Legislation as set forth by the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes, Council of Europe, ETS no.123, appendix VIII and according to national regulations and standards. All experiments were approved by the local Institutional Animal Care and Research Advisory Committee and by the local government, namely the Lower Saxony State Ministry of Food, Agriculture and Consumer Protection in consultation with the Animal Protection Committee with the approval ID: 33.12-42502-04-16/2206.
: All authors agree to participate in this study and are involved according to the author contribution.
: All authors agree with a publication in Geroscience Journal.
: Not applicable